Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 19 2013
Print RSS Feed

Breaking News

Related Searches:
PPD Expands Lab Services into China

January 24, 2008
PPD, Inc. has entered into an exclusive agreement with Peking Union Lawke Biomedical Development Ltd. (PUL), expanding its global central lab services into China. The agreement allows PPD to start providing its full range of central lab services in C…  Read More »
Financial Report: Abbott

January 24, 2008
Abbott 4Q Revenues: $7.2 billion (+16%) 4Q Earnings: $1.2 billion (loss of $476 million 4Q06)* FY Revenues: $25.9 billion (+15%) FY Earnings: $3.6 billion (+110%) Comments: Worldwide pharmaceutical sales in the quarter were $4.2 billio…  Read More »
Financial Report: Gilead Sciences

January 24, 2008
Gilead Sciences   4Q Revenues: $1.1 billion (+22%) 4Q Earnings: $401.6 million (loss of $1.7 billion in 4Q06)* FY Revenues: $4.2 billion (+40%) FY Earnings: $1.6 billion (loss of $1.2 billion FY06)* Comments: Product sales were a r…  Read More »
Financial Report: Pfizer

January 23, 2008
Pfizer 4Q Revenues: $13.1 billion (+4%) 4Q Earnings: $2.9 billion (-70%) FY Revenues: $48.6 billion (+1%) FY Earnings: $8.3 billion (-57%) Comments: Pharmaceutical revenues for the quarter were $11.9 billion, up 2% thanks to favorable…  Read More »
AAIPharma Sterile Site Gets MHRA Approval

January 23, 2008
AAIPharma's sterile manufacturing plant in Charleston, SC received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to produce aseptic and lyophilized products. The approval follows a $1.5 million renovation of the plant a…  Read More »
Myriad Genetics

January 23, 2008
Myriad Genetics, Inc. has expanded its commercial and clinical capabilities with several appointments. The company named Robert Rubens, M.D., vice president of medical affairs, and James DeMarco as vice president of sales for Myriad Pharmaceuticals,…  Read More »
J&J

January 22, 2008
J&J 4Q Revenues: $16.0 billion (+17%) 4Q Earnings: $2.4 billion (+10%) FY Revenues: $61.1 billion (+15%) FY Earnings: $10.6 billion (-4%) Comments: Worldwide pharmaceutical sales were up 7% to $24.9 billion for the year. Sales grow…  Read More »
Teva To Acquire CoGenesys

January 22, 2008
Teva Pharmaceutical Industries Ltd. has entered into a definitive agreement to acquire CoGenesys, Inc. for $400 million cash. CoGenesys is a biopharmaceutical company focused on the development of peptide- and protein-based medicines. CoGenesys was e…  Read More »
Exelixis, BMS To Co-Develop Cancer Drug

January 22, 2008
Bristol-Myers Squibb has exercised its option to develop and commercialize Exelixis' compound XL139. Exelixis will receive a $20 million milestone payment and has exercised its option to co-develop and co-commercialize the drug in the U.S. BMS will l…  Read More »
Quintiles Expands R&D in NC

January 18, 2008
Quintiles Transnational Corp. will open an office in Wilmington, NC, expanding the company's clinical research in pharmaceutical and biotechnology development. The company opened a data processing center in Williamston, NC last January.   …  Read More »
Azopharma, ABP Enter Tablet Tech Pact

January 18, 2008
Azopharma Product Development Group, Inc. and Accu-Break Pharmaceuticals, Inc. (ABP) have signed a strategic alliance agreement in which Azopharma will develop products based on ABP’s Accu-Break tablet technologies. The agreement spans five yea…  Read More »
QLT Inc. Restructures, Slashes Workforce

January 18, 2008
QLT, Inc. has restructured, eliminating 45% of its workforce -- approximately 115 people -- at its Vancouver headquarters and its U.S. subsidiaries, including members of its management team.     The reduction in staff is part of the…  Read More »
Helix, KBI Sign Clinical Development Lyo-Deal

January 18, 2008
Helix BioPharma Corp. has signed an agreement with KBI Biopharma, Inc. to develop a process for preparing L-DOS47 in a lyophilized (freeze-dried powder) vial format for clinical testing.     "This new arrangement advances the C…  Read More »
Precision Pharma Services Becomes Talecris Biotherapeutics

January 17, 2008
Talecris Biotherapeutics, Inc. (TBI) announced the merger of Precision Pharma Services, a wholly-owned subsidiary of Talecris, into TBI. Talecris’ parent company acquired Precision Pharma of Melville, NY in 2005, maintaining its name and separa…  Read More »
Financial Report: Novartis

January 17, 2008
Novartis 4Q Revenues: $9.9 billion (+6%) 4Q Earnings: $931 million (-42%) YTD Revenues: $39.8 billion (+8%) YTD Earnings: $12.0 billion (+66%) Comments: U.S. pharmaceutical sales were down 21% in the quarter, due to the withdrawal of Z…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On
Please visit our sister sites: